HuagongsheHuagongshe Chemistry Print Report · For research reference only
Mci-186 → HCID 178433859, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Mci-186 | HCID 4021 | — |
| Reactant | HCID 178429896 | HCID 178429896 | — |
| Product | HCID 178433859 | HCID 178433859 | — |
Reaction Steps
For the first two days, 60 mg/120 ml of argatroban was diluted with an adequate amount of a transfusion fluid and the resulting solution was intravenously infused constantly over 24 hours. For the following 5 days, 10 mg/20 ml of argatroban was diluted with an adequate amount of a transfusion fluid and the resulting solution was intravenously infused twice daily, that is, in the morning and evening, each over 3 hours; and at the same time, 30 mg/20 ml of edaravone was diluted with an adequate amount of physiological saline and the resulting solution was intravenously infused for 2 weeks twice daily, that is, in the morning and evening, each over 30 minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08183206B2 |
| Source dataset | uspto-grants-2012_05 |
| ORD ID | ord-52f2402c0cf64f7fb44317f0942eaf82 |
| Source note | uspto-grants-2012_05 |